@prefix orcid: .
@prefix this: .
@prefix sub: .
@prefix np: .
@prefix rdf: .
@prefix xsd: .
@prefix rdfs: .
@prefix ns2: .
@prefix ns1: .
@prefix prov: .
@prefix ns3: .
@prefix npx: .
sub:Head {
this: a np:Nanopublication;
np:hasAssertion sub:assertion;
np:hasProvenance sub:provenance;
np:hasPublicationInfo sub:pubInfo .
}
sub:assertion {
ns1:reduce .
}
sub:provenance {
sub:assertion prov:generatedAtTime "2021-12-16T19:43:32.113047"^^xsd:dateTime;
prov:wasGeneratedBy "S&T TWOC project version 2" .
sub:version prov:value "2"^^xsd:integer .
rdf:OBJECT rdfs:label "\"death rate in certain patients subgroups ( positive results )\"" .
rdf:OBJECT-POSITION rdfs:label "44"^^xsd:integer .
rdf:PREDICATE rdfs:label "reduced" .
rdf:PREDICATE-POSITION rdfs:label "[65]" .
rdf:SUBJECT rdfs:label "dexamethasone" .
rdf:SUBJECT-POSITION rdfs:label "51"^^xsd:integer .
rdfs:ABSTRACT-UID ns2:50 "zmo3rgsy" .
rdfs:SENTENCE rdfs:label "Preliminary RECOVERY trial results have shown that dexamethasone reduced death rate in certain patients' subgroups (positive results), whereas both hydroxychloroquine and lopinavir/ritonavir produced no benefit (negative results) versus standard of care (SOC)." .
rdfs:TRIPLE-UID ns3:zmo3rgsy-TRIPLE-ABSTRACT-2 "zmo3rgsy-TRIPLE-ABSTRACT-2" .
rdfs:label "dexamethasone" .
rdfs:label "positive" .
}
sub:pubInfo {
sub:assertion prov:wasDerivedFrom .
sub:sig npx:hasAlgorithm "RSA";
npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB";
npx:hasSignature "GtUZcKD5FxrGIXRXm4vqzEll+DUny3CVMJazJ0wPqPXgmh5Tn1uyGQROGOaKS2RIzMlCF9i0v+H0pK5CRjNy2SJ9DhYSR8xaMfWLPUAy3ZFMKUInScQF/Io0IGbZKnbJLtsmF9tSGcsladrfwaZoggkJrhU+J2X1A6p8M7tXk6Q=";
npx:hasSignatureTarget this: .
this: prov:generatedAtTime "2021-12-16T19:43:32.113047"^^xsd:dateTime;
prov:wasAttributedTo orcid:0000-0002-8954-0470 .
}